The effect of atorvastatin on the blood-brain barrier biomarkers in acute intracerebral hemorrhage, a pilot clinical trial

IF 1.3 Q4 CLINICAL NEUROLOGY Brain Hemorrhages Pub Date : 2023-06-01 DOI:10.1016/j.hest.2022.07.004
Leila Simani , Mahtab Ramezani , Nasrin Ahmadi , Fatima Abazari , Samira Raminfard , Maziyar Shojaei , Anahita Zoghi , Ehsan Karimialavijeh , Seyed Hossein Aghamiri , Hossein Pakdaman
{"title":"The effect of atorvastatin on the blood-brain barrier biomarkers in acute intracerebral hemorrhage, a pilot clinical trial","authors":"Leila Simani ,&nbsp;Mahtab Ramezani ,&nbsp;Nasrin Ahmadi ,&nbsp;Fatima Abazari ,&nbsp;Samira Raminfard ,&nbsp;Maziyar Shojaei ,&nbsp;Anahita Zoghi ,&nbsp;Ehsan Karimialavijeh ,&nbsp;Seyed Hossein Aghamiri ,&nbsp;Hossein Pakdaman","doi":"10.1016/j.hest.2022.07.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>Prior studies have shown statins provide neuroprotection by targeting secondary brain injury pathways and regulating cytokine production. We aimed to evaluate the association between statin administration and molecular outcomes in acute Intracranial hemorrhages (ICHs).</p></div><div><h3>Methods</h3><p>Adult patients with acute spontaneous ICH were recruited and randomly allocated into two groups: group A received atorvastatin (40 mg/day) orally in addition to routine antihypertensive medications, while group B only received routine antihypertensives. Serum levels of matrix metalloproteinase-9 (MMP-9), and vascular endothelial growth factor (VEGF), as primary outcomes, were measured at baseline, and after 45 days.</p></div><div><h3>Results</h3><p>Thirty-nine ICH patients (group A: 20; group B: 19) were analyzed. A notable elevation in VEGF and a reduction in MMP-9 levels were detected in group A compared to those in group B (P-value = 0.024 and 0.008, respectively).</p></div><div><h3>Conclusion</h3><p>Our data suggest that atorvastatin in the acute phase of ICH could improve the serum levels of neuroprotective molecular biomarkers.</p></div>","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain Hemorrhages","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2589238X2200047X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

Prior studies have shown statins provide neuroprotection by targeting secondary brain injury pathways and regulating cytokine production. We aimed to evaluate the association between statin administration and molecular outcomes in acute Intracranial hemorrhages (ICHs).

Methods

Adult patients with acute spontaneous ICH were recruited and randomly allocated into two groups: group A received atorvastatin (40 mg/day) orally in addition to routine antihypertensive medications, while group B only received routine antihypertensives. Serum levels of matrix metalloproteinase-9 (MMP-9), and vascular endothelial growth factor (VEGF), as primary outcomes, were measured at baseline, and after 45 days.

Results

Thirty-nine ICH patients (group A: 20; group B: 19) were analyzed. A notable elevation in VEGF and a reduction in MMP-9 levels were detected in group A compared to those in group B (P-value = 0.024 and 0.008, respectively).

Conclusion

Our data suggest that atorvastatin in the acute phase of ICH could improve the serum levels of neuroprotective molecular biomarkers.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
阿托伐他汀对急性脑出血患者血脑屏障生物标志物的影响,一项试点临床试验
目的先前的研究表明,他汀类药物通过靶向继发性脑损伤途径和调节细胞因子的产生来提供神经保护。我们旨在评估他汀类药物给药与急性颅内出血(ICHs)分子结果之间的关系。方法招募成年自发性ICH患者,并将其随机分为两组:A组除常规降压药物外,还口服阿托伐他汀(40mg/天),而B组仅接受常规降压药物。在基线和45天后测量血清基质金属蛋白酶-9(MMP-9)和血管内皮生长因子(VEGF)水平,作为主要结果。结果分析了39例脑出血患者(A组:20例;B组:19例)。与B组相比,A组VEGF显著升高,MMP-9水平显著降低(P值分别为0.024和0.008)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Brain Hemorrhages
Brain Hemorrhages Medicine-Surgery
CiteScore
2.90
自引率
0.00%
发文量
52
审稿时长
22 days
期刊最新文献
Recent trends of treatment strategies and outcomes of basal ganglia hemorrhages at a single institution Hemorrhage of the hypothalamic cavernous malformation. Clinical case of surgical treatment Effect of mesenchymal stem cell-derived exosomes on the inflammatory response after stroke VASP, HCLS1, MSN, and EZR: Key molecular beacons in the pathophysiology of perihematomal edema Post-Intracerebral hemorrhage Brain hemorrhages in traumatic brain injury and the excess burden conferred by anticoagulants and antiplatelets
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1